Sancuso (Kyowa Kirin, Inc.)


Welcome to the PulseAid listing for the Sancuso drug offered from Kyowa Kirin, Inc.. This Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Kyowa Kirin, Inc.
NON-PROPRIETARY NAME: granisetron
SUBSTANCE NAME: GRANISETRON
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
ROUTE: TRANSDERMAL
DOSAGE FORM: PATCH
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-09-12
END MARKETING DATE: 0000-00-00


Sancuso HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSancuso from Kyowa Kirin, Inc.
LABELER NAME: Kyowa Kirin, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 3.1(mg/24h)
START MARKETING DATE: 2008-09-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42747-726_f743a972-af5d-4b51-9431-e1f5575fc638
PRODUCT NDC: 42747-726
APPLICATION NUMBER: NDA022198

Other GRANISETRON Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Heron TherapeuticsSUSTOL
Kyowa Kirin, Inc.Sancuso
Physicians Total Care, Inc.Sancuso